Skip to main
HSIC

Henry Schein (HSIC) Stock Forecast & Price Target

Henry Schein (HSIC) Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 8%
Buy 42%
Hold 42%
Sell 8%
Strong Sell 0%

Bulls say

Henry Schein Inc. demonstrated a solid performance with multiple segments showing growth, particularly in the Global Technology segment, which generated $173 million in revenue with a growth rate of 9.7% as reported. Additionally, the medical products revenue exhibited a strong increase of 6.3% as reported, indicating robust demand in that sector. Furthermore, the anticipated mid-single-digit growth in adjusted EBITDA for FY 2025 reinforces a positive outlook for the company's financial health and operational efficiency.

Bears say

Henry Schein Inc's recent financial performance delivered disappointing results, particularly in profitability, with gross margins reported at 31.4%, falling short of expectations by 110 basis points. Furthermore, the company's revenue trajectory revealed challenges, with US dental merchandise revenue declining by 1.2% amidst pricing pressure, while international revenues faced a similar decline when adjusted for local currencies. The outlook for adjusted EBITDA has also been revised downward, now projected at $1.090 billion for FY/25, reflecting a continued concern about the company's ability to maintain profitability amidst these headwinds.

Henry Schein (HSIC) has been analyzed by 12 analysts, with a consensus rating of Hold. 8% of analysts recommend a Strong Buy, 42% recommend Buy, 42% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Henry Schein (HSIC) Forecast

Analysts have given Henry Schein (HSIC) a Hold based on their latest research and market trends.

According to 12 analysts, Henry Schein (HSIC) has a Hold consensus rating as of Dec 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $77.08, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $77.08, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Henry Schein (HSIC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.